Literature DB >> 1720332

Comparative analysis of the influences of IL-1, IL-3 and GM-CSF on the commitment of granulocyte-macrophage progenitors in vitro.

J Maciejewski1, H Weber, K Neuhaus, M Wächter, E Elstner, F R Seiler, H D Volk.   

Abstract

Our experiments were directed towards the detection of the influence of interleukin-1 (IL-1); interleukin-3 (IL-3), and granulocyte-macrophage colony-stimulating factor (GM-CSF) on the generation of granulocyte-macrophage progenitor cells. We also set out to examine whether this process is connected with changes within the early precursor cell compartment. Bone marrow suspension cultures (12 days) supplemented with these cytokines were tested for the presence of GM colony-forming cells (GM-CFC) in a colony-forming unit assay. The percentage of CD34+ and HLA-DR+ as well as the number of blasts and promyelocytes were estimated cytofluorometrically and morphologically. The proliferative effect of GM-CSF was associated with a net increase of GM-CFC and HLA-DR+ myeloid cells and a decrease in the percentage of CD34+ early precursor cells. IL-3 acted similarly and also caused an absolute decrease of CD34+ cells in the cultures. IL-1 did not stimulate the generation of blasts or GM-CFC but elevated the number of CD34- as well as HLA-DR-expressing cells in the cultures. These results imply that GM-CSF supported the maintenance of hematopoiesis in vitro. The transition from early precursor cells to committed myeloid progenitor cells (GM-CFC) and more mature precursor cells (G-CFC, M-CFC) may be supported by GM-CSF without affecting the self-renewing capacity of CD34+ early precursors. In contrast, the blast-generating and proliferation-inducing action of IL-3 is associated with a drop in the total number of CD34+ stem cells. An efficient renewal of this population obviously depends on the presence of IL-1.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1720332     DOI: 10.1007/bf01698372

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  30 in total

1.  Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retrovirus-mediated gene transfer into hematopoietic stem cells.

Authors:  D M Bodine; S Karlsson; A W Nienhuis
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

Review 2.  A role for class-II major histocompatibility complex antigens in the regulation of myelopoiesis.

Authors:  H E Broxmeyer; B Dupont
Journal:  Prog Allergy       Date:  1985

Review 3.  Colony-stimulating factors, cytokines and hematopoiesis.

Authors:  N Nakayama; K Hatake; A Miyajima; K Arai; T Yokota
Journal:  Curr Opin Immunol       Date:  1989-10       Impact factor: 7.486

4.  Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer.

Authors:  M Bronchud; J H Scarffe; N Thatcher; D Crowther; L M Souza; N K Alton; N G Testa; T M Dexter
Journal:  Behring Inst Mitt       Date:  1988-08

5.  Regulation of hemopoietic progenitor cell proliferation.

Authors:  C J Eaves; A C Eaves
Journal:  Behring Inst Mitt       Date:  1988-08

6.  Analysis in serum-free culture of the targets of recombinant human hemopoietic growth factors: interleukin 3 and granulocyte/macrophage-colony-stimulating factor are specific for early developmental stages.

Authors:  Y Sonoda; Y C Yang; G G Wong; S C Clark; M Ogawa
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

7.  Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver--conditioned medium.

Authors:  K M Zsebo; J Wypych; I K McNiece; H S Lu; K A Smith; S B Karkare; R K Sachdev; V N Yuschenkoff; N C Birkett; L R Williams
Journal:  Cell       Date:  1990-10-05       Impact factor: 41.582

8.  Recombinant human stem cell factor synergises with GM-CSF, G-CSF, IL-3 and epo to stimulate human progenitor cells of the myeloid and erythroid lineages.

Authors:  I K McNiece; K E Langley; K M Zsebo
Journal:  Exp Hematol       Date:  1991-03       Impact factor: 3.084

9.  Effects of hematopoietin-1 and interleukin 1 activities on early hematopoietic cells of the bone marrow.

Authors:  K M Zsebo; J Wypych; V N Yuschenkoff; H Lu; P Hunt; P P Dukes; K E Langley
Journal:  Blood       Date:  1988-04       Impact factor: 22.113

10.  Synergism between interleukin-6 and interleukin-3 in supporting proliferation of human hematopoietic stem cells: comparison with interleukin-1 alpha.

Authors:  A G Leary; K Ikebuchi; Y Hirai; G G Wong; Y C Yang; S C Clark; M Ogawa
Journal:  Blood       Date:  1988-06       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.